|Articles|January 15, 2021
Supplements and Featured Publications
- The Effect of Intravenous Taxane-Related Toxicities on Metastatic Breast Cancer Disease Treatment and Healthcare Costs
The Effect of Intravenous Taxane-Related Toxicities on Metastatic Breast Cancer Disease Treatment and Healthcare Costs
Advertisement
This publication was supported by Athenex Oncology.
This AJMC® Clinical Brief explores the effect that taxane-related toxicities have on the treatment of metastatic breast cancer and healthcare costs, including the economic and clinical burdens. This publication also includes thought leader perspectives from the Medical Director of Managed Care at OneOncology, John Fox, MD, MHA.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD
4
Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making
5
